Co-Diagnostics, Inc. (CODX) financial statements (2021 and earlier)

Company profile

Business Address 4049 SOUTH HIGHLAND DRIVE
SALT LAKE CITY, UT 84124
State of Incorp. NY
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments47114
Cash and cash equivalents43114
Short-term investments4   
Receivables1200 
Inventory, net of allowances, customer advances and progress billings8000
Inventory8000
Prepaid expense0001
Other undisclosed current assets1   
Total current assets:68214
Noncurrent Assets
Property, plant and equipment1000
Other undisclosed noncurrent assets2000
Total noncurrent assets:3110
TOTAL ASSETS:71225
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4000
Accounts payable1000
Accrued liabilities3000
Deferred revenue0 
Debt  2 
Due to related parties0000
Deferred revenue and credits0
Other undisclosed current liabilities 0  
Total current liabilities:5021
Noncurrent Liabilities
Long-term debt and lease obligation, including:   0
Other undisclosed long-term debt and lease obligation   0
Liabilities, other than long-term debt0000
Deferred revenue and credits0
Due to related parties000 
Other undisclosed noncurrent liabilities   (0)
Total noncurrent liabilities:0000
Total liabilities:5031
Stockholders' equity
Stockholders' equity attributable to parent672(1)4
Preferred stock 0  
Common stock0000
Additional paid in capital49271816
Retained earnings (accumulated deficit)18(25)(19)(12)
Total stockholders' equity:672(1)4
TOTAL LIABILITIES AND EQUITY:71225

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues75000
Revenue, net0
Cost of revenue(17)(0)(0)(0)
Gross profit:58000
Operating expenses(16)(6)(6)(5)
Operating income (loss):42(6)(6)(5)
Nonoperating income (expense)1(0)(0)0
Investment income, nonoperating1  0
Other nonoperating expense (0)(0) 
Interest and debt expense (0)(0)(2)
Income (loss) from continuing operations before equity method investments, income taxes:43(6)(6)(7)
Other undisclosed income (loss) from continuing operations before income taxes 00(0)
Income (loss) from continuing operations before income taxes:43(6)(6)(7)
Income tax expense(0)   
Net income (loss) available to common stockholders, diluted:42(6)(6)(7)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):42(6)(6)(7)
Comprehensive income (loss), net of tax, attributable to parent:42(6)(6)(7)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: